Evaluation of medicinal products for the treatment of irritable bowel syndrome

Keywords Irritable bowel syndrome, Rome criteria, patient reported outcome (PRO), health related quality of life (HrQoL)
Description This document addresses the European Union regulatory position in the main topics of clinical development of new medicinal products in the treatment of irritable bowel syndrome.

How useful was this page?

Add your rating